Benitec Biopharma (BNTC) Total Current Liabilities (2019 - 2025)
Benitec Biopharma (BNTC) posted Total Current Liabilities of $2.8 million for Q4 2025, up 38.32% sequentially from $2.0 million in Q3 2025, and down 9.32% YoY from $3.1 million in Q4 2024.
Benitec Biopharma (BNTC) Total Current Liabilities (2019 - 2025) Analysis & Trends
Benitec Biopharma has reported Total Current Liabilities for 7 years, with the latest figure at $2.8 million in Q4 2025.
- Quarterly Total Current Liabilities fell 9.32% year-over-year to $2.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.8 million (down 9.32% YoY) and the FY2025 annual result came in at $1.8 million, down 63.4% from the prior year.
- Total Current Liabilities climbed to $2.8 million in Q4 2025 per BNTC's latest filing, from $2.0 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $7.0 million in Q1 2025 and troughed at $1.4 million in Q2 2021.
- A 5-year average of $3.2 million and a median of $2.9 million in 2022 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2021 and 2025: Total Current Liabilities surged 218.36% in 2021, then slumped 63.4% in 2025.
- Over 5 years, Total Current Liabilities stood at $2.5 million in 2021, then grew by 0.36% to $2.5 million in 2022, then jumped by 130.86% to $5.7 million in 2023, then sank by 46.24% to $3.1 million in 2024, then dropped by 9.32% to $2.8 million in 2025.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $2.8 million, $2.0 million, and $1.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 354.06 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 2.12 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4.22 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 630.93 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.51 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Benitec Biopharma | 577.39 Mn | 388.49 Mn | - | 2.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.80 Mn |
| Sep 30, 2025 | 2.03 Mn |
| Jun 30, 2025 | 1.80 Mn |
| Mar 31, 2025 | 7.03 Mn |
| Dec 31, 2024 | 3.09 Mn |
| Sep 30, 2024 | 4.55 Mn |
| Jun 30, 2024 | 4.92 Mn |
| Mar 31, 2024 | 3.44 Mn |
| Dec 31, 2023 | 5.75 Mn |
| Sep 30, 2023 | 4.53 Mn |
| Jun 30, 2023 | 3.98 Mn |
| Mar 31, 2023 | 3.15 Mn |
| Dec 31, 2022 | 2.49 Mn |
| Sep 30, 2022 | 3.01 Mn |
| Jun 30, 2022 | 2.53 Mn |
| Mar 31, 2022 | 1.91 Mn |
| Dec 31, 2021 | 2.48 Mn |
| Sep 30, 2021 | 1.60 Mn |
| Jun 30, 2021 | 1.37 Mn |
| Mar 31, 2021 | 2.44 Mn |